146 related articles for article (PubMed ID: 36462771)
1. Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density.
O'Donohue AK; Xiao Y; Lee LR; Schofield T; Cheng TL; Munns CF; Baldock PA; Schindeler A
Bone; 2023 Feb; 167():116636. PubMed ID: 36462771
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
[TBL] [Abstract][Full Text] [Related]
3. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
[TBL] [Abstract][Full Text] [Related]
4. Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.
Yang H; Büttner A; Albiol L; Julien C; Thiele T; Figge C; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
Sci Rep; 2020 Dec; 10(1):22299. PubMed ID: 33339872
[TBL] [Abstract][Full Text] [Related]
5. Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.
Lim KE; Bullock WA; Horan DJ; Williams BO; Warman ML; Robling AG
Bone; 2021 Feb; 143():115708. PubMed ID: 33164872
[TBL] [Abstract][Full Text] [Related]
6. Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
Cejka D; Parada-Rodriguez D; Pichler S; Marculescu R; Kramer I; Kneissel M; Gross T; Reisinger A; Pahr D; Monier-Faugere MC; Haas M; Malluche HH
Kidney Int; 2016 Oct; 90(4):828-34. PubMed ID: 27528549
[TBL] [Abstract][Full Text] [Related]
7. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
Qin W; Zhao W; Li X; Peng Y; Harlow LM; Li J; Qin Y; Pan J; Wu Y; Ran L; Ke HZ; Cardozo CP; Bauman WA
Osteoporos Int; 2016 Dec; 27(12):3627-3636. PubMed ID: 27436301
[TBL] [Abstract][Full Text] [Related]
8. Mef2c deletion in osteocytes results in increased bone mass.
Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
[TBL] [Abstract][Full Text] [Related]
9. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume.
Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG
Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410
[TBL] [Abstract][Full Text] [Related]
10. Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta.
Marulanda J; Tauer JT; Boraschi-Diaz I; Bardai G; Rauch F
Sci Rep; 2023 Mar; 13(1):5010. PubMed ID: 36973504
[TBL] [Abstract][Full Text] [Related]
11. Mechanical load increases in bone formation via a sclerostin-independent pathway.
Morse A; McDonald MM; Kelly NH; Melville KM; Schindeler A; Kramer I; Kneissel M; van der Meulen MC; Little DG
J Bone Miner Res; 2014 Nov; 29(11):2456-67. PubMed ID: 24821585
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formation.
Nakamura K; Koide M; Kobayashi Y; Yamashita T; Matsushita M; Yasuda H; Ishihara Y; Yoshinari N; Udagawa N
J Periodontal Res; 2023 Aug; 58(4):769-779. PubMed ID: 37154419
[TBL] [Abstract][Full Text] [Related]
13. Effects of Long-Term Sclerostin Deficiency on Trabecular Bone Mass and Adaption to Limb Loading Differ in Male and Female Mice.
Albiol L; Büttner A; Pflanz D; Mikolajewicz N; Birkhold AI; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
Calcif Tissue Int; 2020 Apr; 106(4):415-430. PubMed ID: 31873756
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.
Kedlaya R; Veera S; Horan DJ; Moss RE; Ayturk UM; Jacobsen CM; Bowen ME; Paszty C; Warman ML; Robling AG
Sci Transl Med; 2013 Nov; 5(211):211ra158. PubMed ID: 24225945
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice.
Koide M; Yamashita T; Nakamura K; Yasuda H; Udagawa N; Kobayashi Y
Bone; 2022 Jul; 160():116401. PubMed ID: 35381389
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
17. Mef2c regulates bone mass through Sost-dependent and -independent mechanisms.
Morfin C; Sebastian A; Wilson SP; Amiri B; Murugesh DK; Hum NR; Christiansen BA; Loots GG
Bone; 2024 Feb; 179():116976. PubMed ID: 38042445
[TBL] [Abstract][Full Text] [Related]
18. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
[TBL] [Abstract][Full Text] [Related]
19. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
Ryan ZC; Ketha H; McNulty MS; McGee-Lawrence M; Craig TA; Grande JP; Westendorf JJ; Singh RJ; Kumar R
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6199-204. PubMed ID: 23530237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
